title: Xenograft models of head and neck cancers.
abstract: Head and neck cancers are among the most prevalent tumors in the world. Despite advances in the treatment of head and neck tumors, the survival of patients with these cancers has not markedly improved over the past several decades because of our inability to control and our poor understanding of the regional and distant spread of this disease. One of the factors contributing to our poor understanding may be the lack of reliable animal models of head and neck cancer metastasis. The earliest xenograft models in which human tumor cells were grown in immunosuppressed mice involved subcutaneous implantation of human head and neck cancer cell lines. Subcutaneous xenograft models have been popular because they are easy to establish, easy to manage, and lend themselves to ready quantitation of the tumor burden. More recently, orthotopic xenograft models, in which the tumor cells are implanted in the tumor site of origin, have been used with greater frequency in animal studies of head and neck cancers. Orthotopic xenograft models are advantageous for their ability to mimic local tumor growth and recapitulate the pathways of metastasis seen in human head and neck cancers. In addition, recent innovations in cell labeling techniques and small-animal imaging have enabled investigators to monitor the metastatic process and quantitate the growth and spread of orthopically implanted tumors. This review summarizes the progress in the development of murine xenograft models of head and neck cancers. We then discuss the advantages and disadvantages of each type of xenograft model. We also discuss the potential for these models to help elucidate the mechanisms of regional and distant metastasis, which could improve our ability to treat head and neck cancers.
authors.affiliation: Department of Head and Neck Surgery, The University of Texas M, D, Anderson Cancer Center, Houston, Texas, USA. dsano@mdanderson.org
authors.forename: Daisuke
authors.initials: D
authors.lastname: Sano
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Myers
mesh_terms: D000818:Animals; D006258:Head and Neck Neoplasms / Q000473:pathology*; D006801:Humans; D051379:Mice; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D014183:Transplantation, Heterologous
references.citation: Clin Cancer Res. 2002 Jan;8(1):293-8
references.pmid: 11801572
references.citation: Arch Otolaryngol Head Neck Surg. 2008 Feb;134(2):190-7
references.pmid: 18283163
references.citation: Lab Invest. 2002 Nov;82(11):1563-71
references.pmid: 12429816
references.citation: Neoplasia. 2000 Jan-Apr;2(1-2):41-52
references.pmid: 10933067
references.citation: Eur J Cancer B Oral Oncol. 1995 Jul;31B(4):216-21
references.pmid: 7492915
references.citation: Arch Otorhinolaryngol. 1984;239(1):69-79
references.pmid: 6691837
references.citation: Cancer Res. 2004 Nov 1;64(21):7977-84
references.pmid: 15520205
references.citation: Mol Cancer Ther. 2007 Jun;6(6):1785-92
references.pmid: 17575107
references.citation: Otolaryngol Head Neck Surg. 1990 Nov;103(5 ( Pt 1)):766-74
references.pmid: 2126099
references.citation: Cancer Metastasis Rev. 1998-1999;17(3):279-84
references.pmid: 10352881
references.citation: Cell. 1994 Oct 21;79(2):185-8
references.pmid: 7525076
references.citation: Lancet Oncol. 2002 Sep;3(9):546-56
references.pmid: 12217792
references.citation: Eur J Cancer. 2004 Apr;40(6):827-36
references.pmid: 15120038
references.citation: Clin Cancer Res. 2005 Mar 1;11(5):1713-21
references.pmid: 15755992
references.citation: Br J Cancer. 1983 Jan;47(1):1-13
references.pmid: 6336942
references.citation: Clin Pharmacol Ther. 2009 Feb;85(2):217-21
references.pmid: 19005462
references.citation: Mol Cancer Ther. 2006 Nov;5(11):2696-705
references.pmid: 17121916
references.citation: Clin Cancer Res. 2009 Jan 15;15(2):485-91
references.pmid: 19147753
references.citation: Clin Cancer Res. 2008 Nov 15;14(22):7348-57
references.pmid: 19010850
references.citation: Br J Cancer. 2001 May 18;84(10):1424-31
references.pmid: 11355958
references.citation: Clin Cancer Res. 2006 Jan 15;12(2):600-7
references.pmid: 16428506
references.citation: Cancer Res. 1997 May 15;57(10):2042-7
references.pmid: 9158003
references.citation: Int J Cancer. 1979 Dec 15;24(6):733-8
references.pmid: 544528
references.citation: Clin Exp Metastasis. 1999 Jun;17(4):277-82
references.pmid: 10545013
references.citation: Oral Oncol. 2002 Oct;38(7):664-9
references.pmid: 12167418
references.citation: Clin Cancer Res. 2005 Feb 1;11(3):971-81
references.pmid: 15709162
references.citation: Laryngoscope. 1998 Nov;108(11 Pt 1):1686-91
references.pmid: 9818827
references.citation: Laryngoscope. 1985 Jan;95(1):43-56
references.pmid: 3855324
references.citation: Clin Cancer Res. 2008 Aug 15;14(16):5081-9
references.pmid: 18698025
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: J Oral Maxillofac Surg. 2003 Jun;61(6):696-700
references.pmid: 12796881
references.citation: Oncogene. 2008 Jun 5;27(25):3527-38
references.pmid: 18223693
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Acta Pathol Microbiol Scand A. 1972;80(6):713-7
references.pmid: 4654793
references.citation: Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S134-9
references.pmid: 14508091
references.citation: Clin Cancer Res. 2003 Aug 1;9(8):3183-9
references.pmid: 12912971
references.citation: Eur J Cancer. 2004 Apr;40(6):852-7
references.pmid: 15120041
references.citation: Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3425-34
references.pmid: 16740767
references.citation: Eur J Cancer. 2004 Apr;40(6):802-20
references.pmid: 15120036
references.citation: J Natl Cancer Inst. 1977 Nov;59(5):1537-44
references.pmid: 909110
references.citation: J Oral Pathol Med. 2007 Jul;36(6):363-70
references.pmid: 17559499
references.citation: Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):411-20
references.pmid: 19380367